Beijing Chieftain Control Technology Group Co

Beijing Chieftain Control Technology Group Co Current Liabilities

The Current Liabilities of Beijing Chieftain Control Technology Group Co (300430.SZ) as of Nov 2, 2026 is 746.32 M CNY. In the previous year, Current Liabilities was 1.22 B CNY — a change of -39.04% (lower).

Current Liabilities

746.32 MCNY

YoY

-39.04%

Last updated:

Current Liabilities of Beijing Chieftain Control Technology Group Co is 2025 746.32 M CNY. Current Liabilities of Beijing Chieftain Control Technology Group Co was 2024 1.22 B CNY. It decreases by -39.04% lower compared to the previous year.

The Beijing Chieftain Control Technology Group Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
183.13 M CNY
Jan 1, 2019
319.25 M CNY
Jan 1, 2020
542.12 M CNY
Jan 1, 2021
795.24 M CNY
Jan 1, 2022
943.63 M CNY
Jan 1, 2023
1.04 B CNY
Jan 1, 2024
1.22 B CNY
Jan 1, 2025
746.32 M CNY
The Beijing Chieftain Control Technology Group Co Current Liabilities history
YEARCurrent LiabilitiesYoY
746.32 MCNY-39.04%
1.22 BCNY+18.16%
1.04 BCNY+9.81%
943.63 MCNY+18.66%
795.24 MCNY+46.69%
542.12 MCNY+69.81%
319.25 MCNY+74.33%
183.13 MCNY-48.11%
352.94 MCNY+28.00%
275.74 MCNY-2.50%
282.81 MCNY-13.68%
327.62 MCNY-3.95%
341.10 MCNY+36.31%
250.23 MCNY+68.86%
148.18 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Chieftain Control Technology Group Co Stock analysis

What does Beijing Chieftain Control Technology Group Co do? Beijing Chieftain Control Engineering Technology Co. Ltd. generates revenue through the provision of pharmaceutical and biotechnology industrial automation control systems. The company offers four product series: Fermentation and Synthesis, Purification, Product Preparation, and Auxiliary Process, which are designed for large and medium-sized pharmaceutical and biotechnology firms. These systems are based on the firm's independent research and development of core technologies and its production of key equipment and components. The target customers are pharmaceutical and biotechnology companies that require automation control solutions for their production processes. The company's business model relies on delivering integrated automation control system products and solutions tailored to the specific needs of its clients in the pharmaceutical and biotechnology sectors. By focusing on core technologies developed in-house and manufacturing key components internally, Beijing Chieftain Control Engineering Technology Co. Ltd. ensures the quality and reliability of its offerings. This approach allows the company to serve a segment of the market that demands high-precision automation solutions for complex production environments. Beijing Chieftain Control Engineering Technology Co. Ltd. targets large and medium-sized pharmaceutical and biotechnology companies as its primary customers. These clients purchase the company's automation control systems to optimize their production processes, particularly in areas such as fermentation, synthesis, purification, and product preparation. The firm's emphasis on independent R&D and in-house production of key components differentiates its offerings in the market, providing a competitive edge for its target segments. Beijing Chieftain Control Technology Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Chieftain Control Technology Group Co stock

Current Liabilities of Beijing Chieftain Control Technology Group Co is 746.32 M CNY in 2025.

Current Liabilities of Beijing Chieftain Control Technology Group Co changed from 1.22 B CNY to 746.32 M CNY, representing a -39.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Beijing Chieftain Control Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Beijing Chieftain Control Technology Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Beijing Chieftain Control Technology Group Co

All Key Metrics — Beijing Chieftain Control Technology Group Co